Schedule 13G ownership disclosure

BELLEROPHON THERAPEUTICS INC

Security class unavailable · CUSIP: 078771300

Event date: 2023-06-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-23-000082
Form type
SC 13G/A
Filer
Bellerophon Therapeutics, Inc.
CIK
CIK 1600132
Filed
Jun 09, 2023
Reporting period
Jun 06, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub